Detection of occult metastases in lung carcinomas: Progress and implications for lung cancer staging

Journal of Surgical Oncology

Volumn 69, Issue 4, 1998, Pages 265-274

  Cote, Richard J ^a,d   Hawes, Debra ^a   Chaiwun, Benjaporn ^b   Beattie Jr , Edward J ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bone marrow; Immunohistochemistry; Lung cancer; Lymph nodes; Occult metastases

Indexed keywords

BONE MARROW METASTASIS; CANCER STAGING; CANCER THERAPY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; REVIEW;

BONE MARROW NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032432079     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199812)69:4<265::AID-JSO12>3.0.CO;2-7     Document Type: Review

References (54)

1. Cancer facts and figures - 1997. Atlanta, GA: American Cancer Society; 1997.
2. Minna JD, Pass H, Glatstein EJ, et al.: Cancer of the lung. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott; 1989. p 591-705.
3. Rosenow EC, Carr DT: Bronchogenic carcinoma. CA Cancer J Clin 1979;29:233-246.
4. Beahrs OH, Henson DE, Hutter RVP, et al., editors: American Joint Committee on Cancer manual for staging cancer. 3rd ed. Philadelphia: JB Lippincott; 1988.
5. Martini N, Beattie EJ: Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 1977;74:499-506.
6. Martini N, Flehinger BJ, Nagasaki F, et al.: Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983;86:646-653.
7. Martini N, Flehinger BJ, Zaman MB, et al.: Results of resection in non-oat cell carcinoma of lung with mediastinal metastases. Ann Surg 1983;86:646-653.
8. Mountain CF, Hermes KE: Management implications of surgical staging studies. Prog Cancer Res Ther 1979;11:233-242.
9. Williams DE, Pairolero PC, Davis CS, et al.: Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-76.
10. Mountain CF: A new international staging system for lung cancer. Chest 1986;89(Suppl):225S-233S.
11. Naruke T, Goya T, Tsuchiya R, et al.: Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440.
12. Schabel FM: Rationale for adjuvant chemotherapy. Cancer 1977; 39:2875-2882.
13. Redding WH, Coombes RC, Monaghan P, et al.: Detection of micrometastases in patients with primary breast cancer. Lancet 1983;2:1271-1274.
14. Apostolikas N, Petraki C, Agnantis NJ: The reliability of histologically negative axillary lymph nodes in breast cancer. Pathol Res Pract 1989;184:35-38.
15. Cote RJ, Rosen PP, Hakes TB, et al.: Monoclonal antibodies detect occult breast carcinoma metastases in bone marrow of patients with early stage disease. Am J Surg Pathol 1988;12:333-340.
16. Dearnaley DP, Sloan JP, Imrie S, et al.: Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med 1983;76:359-364.
17. Mansi JL, Berger U, Easton D, et al.: Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. BMJ 1987;295:1093-1096.
18. Porro G, Menard S, Tagliabue E, et al.: Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988;61:2407-2411.
19. Schlimok G, Funke I, Holtzman B, et al.: Micrometastic cancer cells in bone marrow: in vitro detection with anticytokeratin and in vivo with anti-17-1A monoclonal antibody. Proc Natl Acad Sci USA 1987;84:8672-8676.
20. Schlimok G, Funke I, Bock B, et al.: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990;8:831-837.
21. Sedmark DD, Meineke TA, Knechtges DS, et al.: Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-520.
22. Wells CA, Heryet A, Brochier J, et al.: The immunohistochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193-197.
23. Bretton PR, Melamed MR, Fair WR, et al.: Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate 1994;25:108-114.
24. Cote RJ, Beattie EJ, Chaiwun B, et al.: Detection of occult bone marrow metastases in patients with operable lung carcinoma. Ann Surg 1995;222:415-425.
25. Freeman JA, Esrig D, Grossfeld GD, et al.: Incidence of occult lymph node metastases in pathologic stage C (pT3N0) prostate cancer. J Urol 1995;154:474-478.
26. Habubi NY, Clark P, Kaftan SM, et al.: The importance of combining xylene clearance and immunohistochemistry in the accurage staging of colorectal carcinoma. J R Soc Med 1992;85: 386-388.
27. Mansi JL, Berger U, Wilson P, et al.: Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 1988;1139:545-548.
28. Pantel K, Izbicki JR, Angswurm M, et al.: Immunocytochemical detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993;53:1027-1031.
29. Passlick B, Izbicki JR, Kubuschak B, et al.: Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 1994;12:1827-1832.
30. Silly H, Samonigg H, Stoger H, et al.: Micrometastic tumor cells in bone marrow in colorectal carcinoma. Lancet 1992;340:1288.
31. Ellis G, Ferguson M, Yamanak E, et al.: Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 1989;63:2509-2514.
32. Cote RJ, Rosen PP, Lesser ML, et al.: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow metastases. J Clin Oncol 1991;9:1749-1756.
33. Zippelius A, Kufer P, Honold G, et al.: Limitations of reverse-transcriptase polymerase chain reaction analysis for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997;15:2701-2708.
34. Gusterson BA, Ott R: Occult axillary lymph node micrometastases in breast cancer. Lancet 1990;336:434-435.
35. Bostick P, Chi D, Huynh K, et al.: Limitations of specific RT-PCR markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-2640.
36. Datta YH, Adams PT, Drobyski WR, et al.: Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-482.
37. 6-7. Proc Natl Acad Sci USA 1995;92:537-541.
38. Leslie DS, Johnston WW, Daly L, et al.: Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol 1990;94:8-13.
39. Izbicki JR, Passlick B, Hosch SB, et al.: Mode of spread in the early phase of lymphatic metastases in non-small-cell lung cancer: Significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996;112:623-630.
40. Chen ZL, Perez S, Holmes EC, et al.: Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung cancer. J Natl Cancer Inst 1993;85:493-498.
41. Chaiwan B, Saad A, Groshen S, et al.: Detection of occult carcinoma cells in bone marrow and blood: Efficiency of separation, preparation, and limits of detection using immunohistochemical methods. Diagn Oncol 1992;2:267-276.
42. Osborne MP, Asina S, Wong GY, et al.: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system. Cancer Res 1989;49:2510-2513.
43. Osborne MP, Wong GY, Asina S, et al.: Sensitivity of immunochemical detection of breast cancer cells in human bone marrow. Cancer Res 1991;51:2706-2709.
44. Berger U, Bettelheim R, Mansi JL, et al.: The relationship between micrometastases in the bone marrow, histopathologic features in the primary tumor in breast cancer and prognosis. Am J Clin Pathol 1988;90:1-6.
45. Cote RJ, Taylor CR, Neville AM: Detection of occult metastases [review]. The Cancer Journal 1995;8:49-51.
46. Mansi JL, Mesker WE, McDonnell T, et al.: Automated screening for micrometastases in bone marrow smears. J Immunol Methods 1988;112:105-111.
47. Cote RJ, Rosen PP, Old LJ, et al.: Detection of bone marrow micrometastases in patients with early stage breast cancer. Diagn Oncol 1991;1:37-42.
48. Chaiwun B, Saad AD, Chatterjee SJ, et al.: Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases. In: Pathology: state of the art reviews. Volume 4. Philadelphia: Hanley and Belfus, Inc; 1996. p. 155-168.
49. Mesker WE, Marja JM, Oud PS, et al.: Detection of immunocytochemically stained rare events using image analysis. Cytometry 1994;17:209-215.
50. Makarewicz K, McDuffie L, Shi S-R, et al.: Immunohistochemical detection of occult micrometastases using an automated intelligent microscopy system [abstract]. In: Proceedings of the 88th annual meeting of the American Association for Cancer Research; 1997 Apr 14; San Diego, CA. 1997. p 38. Abstract nr 1805.
51. Cote RJ, Shi S-R, Beattie EJ, et al.: Automated detection of occult bone marrow micrometastases in patients with operable lung carcinoma, [abstract]. In: Proceedings of The American Society of Clinical Oncology 33rd annual meeting; 1997 May 17-19; Denver, CO. 1997. p 458a. Abstract nr 1645.
52. Pantel K, Izbicki J, Passlick B, et al.: Frequency and prognostic significance of isolated tumour cells in bone marrow cells in patients with non-small cell lung cancer without overt metastases. Lancet 1996;347:649-653.
53. Ohgami A, Tetsuya M, Kenji S, et al.: Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg 1997;64:363-367.
54. Leonard RCF, Duncan LW, Hay FG: Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res 1990;50: 6545-6548.